U.S. Economic Crisis, Beijing’s Perks, Could Trigger Reverse Brain Drain
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The financial meltdown and widening layoffs in the United States, combined with Beijing's injection of stimulus funds into its pharmaceutical and biotech sectors, could trigger a reverse brain drain in those sectors, according to industry insiders and investors in the U.S. and China
You may also be interested in...
China Will Seize Ranking As Globe's Top Innovative Center From U.S. By 2020: AstraZeneca Survey
BEIJING - A survey commissioned by British-headquartered AstraZeneca that polled public perceptions across three continents - Europe, North America and Asia -predicts that China will dethrone the United States to become the globe's most innovative center by 2020
China Will Seize Ranking As Globe's Top Innovative Center From U.S. By 2020: AstraZeneca Survey
BEIJING - A survey commissioned by British-headquartered AstraZeneca that polled public perceptions across three continents - Europe, North America and Asia -predicts that China will dethrone the United States to become the globe's most innovative center by 2020
San Francisco Aims To Become Primary Gateway For Chinese Biotech Firms Expanding Across Pacific
BEIJING - San Francisco is stepping up its drive to become the North American headquarters for Chinese enterprises expanding across the Pacific and to attract life science firms based in the People's Republic to the Bay Area